Synthesis of β-anti-Substituted α-Amino Acids through Iridium-Catalyzed Alkylation/Chelation-Controlled Nucleophilic Addition

Abstract

An Ir/Ag dual-catalysis method has been developed for the synthesis of β-anti-substituted α-amino acids in high yields and with good enantioselectivities through a ligand/chelation-control strategy. By using this chiral-ligand-control strategy, a natural product for the regulation of a plant-growth hormone was synthesized on a gram scale in three steps.

Key words

iridium catalysis - allylic carbonates - asymmetric catalysis - natural products - dual catalysis - amino acids

Publikationsverlauf

Eingereicht: 21. Januar 2022

Angenommen nach Revision: 11. Februar 2022

Artikel online veröffentlicht:
08. März 2022

• References and Notes

• 1a Yoshimura H, Takegami K, Doe M, Yamashita T, Shibata K, Wakabayashi K, Soga K, Kamisaka S. Phytochemistry 1999; 52: 25
• 1b Randazzo A, Bifulco G, Giannini C, Bucci M, Debitus C, Cirino G, Gomez-Paloma L. J. Am. Chem. Soc. 2001; 123: 10870
• 1c Yoshioka H, Aoki T, Goko H, Nakatsu K, Noda T, Sakakibara H, Take T, Nagata A, Abe J, Wakamiya T, Shiba T, Kaneko T. Tetrahedron Lett. 1971; 12: 2043
• 1d Takita T, Muraoka Y, Yoshioka T, Fuji A, Maeda K, Umezawa H. J. Antibiot. 1972; 25: 755
• 1e Teichert JF, Feringa BL. Angew. Chem. Int. Ed. 2010; 49: 2486
• 2a Edmondson SD, Mastracchio A, Mathvink RJ, He J, Harper B, Park Y.-J, Beconi M, Di Salvo J, Eiermann GJ, He H, Leiting B, Leone JF, Levorse DA, Lyons K, Patel RA, Patel SB, Petrov A, Scapin G, Shang J, Roy RS, Smith A, Wu JK, Xu S, Zhu B, Thornberry NA, Weber AE. J. Med. Chem. 2006; 49: 3614
• 2b Hruby VJ. J. Med. Chem. 2003; 46: 4215
• 2c Toth G, Russell KC, Landis GT, Fang HL, Knapp R, Davis P, Burks TF, Yamamura HI, Hruby VJ. J. Med. Chem. 1992; 35: 2384
• 2d Marigo M, Kjærsgaard A, Juhl K, Gathergood N, Jørgensen KA. Chem. Eur. J. 2003; 9: 2359
• 2e Notz W, Tanaka F, Watanabe S.-i, Chowdari NS, Turner JM, Thayumanavan R, Barbas CF. III. J. Org. Chem. 2003; 68: 9624
• 2f Córdova A, Notz W, Zhong G, Betancort JM, Barbas CF. III. J. Am. Chem. Soc. 2002; 124: 1842
• 2g Ferraris D, Young B, Cox C, Dudding T, Drury WJ. III, Ryzhkov L, Taggi AE, Lectka T. J. Am. Chem. Soc. 2002; 124: 67
• 2h Helmchen G, Dahnz A, Dübon A, Schelwies M, Weihofen R. Chem. Commun. 2007; 675
• 3a Randazzo A, Bifulco G, Giannini C, Bucci M, Debitus C, Cirino G, Gomez-Paloma L. J. Am. Chem. Soc. 2001; 123: 10870
• 3b Roff GJ, Lloyd RC, Turner NJ. J. Am. Chem. Soc. 2004; 126: 4098
• 3c Burk MJ, Gross MF, Martinez JP. J. Am. Chem. Soc. 1995; 117: 9375
• 3d Navarre L, Martinez RM, Genet J.-P, Darses S. J. Am. Chem. Soc. 2008; 130: 6159
• 3e Kanayama T, Yoshida K, Miyabe H, Kimachi T, Takemoto Y. J. Org. Chem. 2003; 68: 6197
• 3f Wei L, Zhu Q, Xu S.-M, Chang X, Wang C.-J. J. Am. Chem. Soc. 2018; 140: 1508
• 3g Huo X, Zhang J, Fu J, He R, Zhang W. J. Am. Chem. Soc. 2018; 140: 2080
• 3h Cheng Q, Tu H.-F, Zheng C, Qu J.-P, Helmchen G, You S.-L. Chem. Rev. 2019; 119: 1855
• 3i Hartwig JF, Stanley LM. Acc. Chem. Res. 2010; 43: 1461

For reviews on asymmetric hydrogenation, see:
• 4a Crépy KV. L, Imamoto T. Adv. Synth. Catal. 2003; 345: 79
• 4b Tang W, Zhang X. Chem. Rev. 2003; 103: 3029
• 4c Tosatti P, Nelson A, Marsden SP. Org. Biomol. Chem. 2012; 10: 3147
• 5 Chen W, Hartwig JF. J. Am. Chem. Soc. 2013; 135: 2068
• 6 Bondzic BP, Farwick A, Liebich J, Eilbracht P. Org. Biomol. Chem. 2008; 6: 3723

For reviews on asymmetric 1,3-dipolar cycloaddition reactions, see:
• 7a Gothelf K, Jørgensen VK. A. Chem. Rev. 1998; 98: 863
• 7b Stanley LM, Sibi MP. Chem. Rev. 2008; 108: 2887
• 7c Naodovic M, Yamamoto H. Chem. Rev. 2008; 108: 3132
• 7d Hashimoto T, Maruoka K. Chem. Rev. 2015; 115: 5366
• 7e Fang G, Bi X. Chem. Soc. Rev. 2015; 44: 8124
• 7f De N, Yoo EJ. ACS Catal. 2018; 8: 48
• 8 The absolute configuration of 4a was deduced from reports in the literature and confirmed through the synthesis of 6 and by comparing its optical rotation with that of the natural product.
• 9 When R¹ = Ph, the diastereoselectivity dropped significantly. The phenyl group might have some unknown interaction with 1a.
• 10a Morimoto Y, Takaishi M, Kinoshita T, Sakaguchi K, Shibata K. Chem. Commun. 2002; 42
• 10b Spangenberg T, Schoenfelder A, Breit B, Mann A. Org. Lett. 2007; 9: 3881
• 11 Yu S, Pan X, Lin X, Ma D. Angew. Chem. Int. Ed. 2005; 44: 135
• 12 Srinivas K, Dangat Y, Kommagalla Y, Vanka K, Ramana CV. Chem. Eur. J. 2017; 23: 7570
• 13 tert-Butyl (2S,3S)-2-Amino-3-{[(4-methoxybenzyl)oxy] methyl}pent-4-enoate (4a); Typical Procedure [Ir(cod)Cl]₂ (4.0 mg, 0.006 mmol, 0.03 equiv), ligand (S,S,S)-L (6.4 mg, 0.012 mmol, 0.06 equiv), and 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD; 2.8 mg, 0.02 mmol, 0.1 equiv) were dissolved in THF (0.5 mL) under N₂, and the mixture was vigorously stirred at 50 °C for 30 min. The resulting dark-red solution was added to a mixture of 1a (88.5 mg, 0.30 mmol, 1.5 equiv), Ag₂CO₃ (5.5 mg, 0.02 mmol, 0.1 equiv), and DABCO (22.5 mg, 0.24 mmol, 1.2 equiv) in a screw-capped glass vial, affording a yellow solution. To this solution was added a solution of the allylic carbonate ester 2a (53 mg, 0.2 mmol, 1.0 equiv) in THF (0.5 mL). The vessel was purged with N₂ and the resulting solution was stirred at r.t. for 8–12 h. The ¹H NMR spectrum of the crude mixture was recorded to determine the diastereomeric ratio of the product. The mixture was then purified by flash chromatography to afford product 3a. The product diastereomers were not separable under these conditions. A 0.1 M solution of 3a (0.2 mmol) in 1:1 THF–H₂O at r.t. was treated with 15% aq citric acid (5.0 mL), and the resulting mixture was stirred at r.t. until the starting material was completely consumed (TLC). The reaction was then quenched by addition of sat. aq NaHCO₃, and the mixture was diluted with EtOAc. The organic phases were separated and the aqueous phase was extracted with EtOAc. The organic phases were combined, dried (Na₂SO₄), filtered, and concentrated under vacuum. The residue was purified by flash chromatography (silica gel, 10%~20% EtOAc/hexans) to give a colorless oil; yield: 62.9 mg (98%); ee 99%. SFC: AD-H column (5.0% i-PrOH–hexanes, 1 mL/min, λ = 200 nm, 25 °C); R_t = 11.48 min (major), 12.48 min (minor). ¹H NMR (400 MHz, CDCl₃): δ = 7.27 (d, J = 8.4 Hz, 2 H), 6.90–6.85 (m, 2 H), 5.73–5.61 (m, 1 H), 5.19–5.08 (m, 2 H), 4.52–4.41 (m, 2 H), 3.80 (s, 3 H), 3.65–3.57 (m, 2 H), 3.49 (dd, J = 9.3, 5.8 Hz, 1 H), 2.86 (tt, J = 8.7, 4.6 Hz, 1 H), 1.44 (s, 9 H). ¹³C{¹H} NMR (75 MHz, CDCl₃): δ = 174.3, 159.2, 133.8, 130.3, 129.3, 118.6, 113.8, 81.0, 72.8, 70.1, 55.2, 54.9, 46.9, 28.1. HRMS (ESI): m/z [M + H]⁺ calcd for C₁₈H₂₈NO₄: 322.2013; found: 322.2012.